◆英語タイトル:ProteoMediX AG - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010076
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月27日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
ProteoMediX AG (ProteoMediX) is a medical diagnostic company which identifies and develops novel biomarkers for the early detection of cancer and the personalized treatment. The company develops non-invasive diagnostic tests for the detection, prognosis, stratification, and therapy-selection of prostate cancer. Its biomarkers are discovered using a genetics-guided discovery approach and are used in detecting PI3K/PTEN cancer pathway. ProteoMediX offers proteomics technologies that are used to analyze glycosylated proteins in prostate tissue and serum from wild-type mice and mice with prostate-specific deletion of the tumor suppressor PTEN. The company serves patients with prostate and other types of cancer. ProteoMediX is headquartered in Schlieren, Switzerland.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ProteoMediX AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
ProteoMediX AG Company Overview 4
ProteoMediX AG Company Snapshot 4
ProteoMediX AG Pipeline Products and Ongoing Clinical Trials Overview 4
ProteoMediX AG – Pipeline Analysis Overview 7
ProteoMediX AG – Key Facts 7
ProteoMediX AG – Major Products and Services 8
ProteoMediX AG Pipeline Products by Development Stage 9
ProteoMediX AG Pipeline Products Overview 11
Diagnostic Test – Prostate Cancer 11
Diagnostic Test – Prostate Cancer Product Overview 11
Prostate Cancer Prognosis Assay 12
Prostate Cancer Prognosis Assay Product Overview 12
Prostate Cancer Stratification Assay 13
Prostate Cancer Stratification Assay Product Overview 13
ProteoMediX Prostate Cancer Test 14
ProteoMediX Prostate Cancer Test Product Overview 14
ProteoMediX AG – Key Competitors 15
ProteoMediX AG – Key Employees 16
ProteoMediX AG – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
ProteoMediX AG, Recent Developments 18
Jun 21, 2017: Dr. Helge Lubenow elected as a new member to the Board of Directors 18
Mar 27, 2017: Recent Clinical Study Results of ProteoMediX’ Prostate Cancer Test Presented at the 2017 Annual European Association of Urology Congress 18
Jan 13, 2017: ProteoMediX receives ISO 13485:2012 Certification 18
Sep 08, 2014: CTI supports the development of a prostate cancer risk stratification test 19
Jun 17, 2014: Harry Welten joins the Board of Directors of ProteoMediX 19
May 19, 2014: ProteoMediX adds Mark Emberton as new clinical advisor 19
Apr 26, 2013: ProteoMediX Announces Publication of Results of its Biomarkers 19
Jul 21, 2011: New Publication Proofs Prognostic Potential Of ProteoMediX’ Proprietary Biomarkers 20
Appendix 21
Methodology 21
About GlobalData 23
Contact Us 23
Disclaimer 24
List of Tables
ProteoMediX AG Pipeline Products and Ongoing Clinical Trials Overview 4
ProteoMediX AG Pipeline Products by Equipment Type 5
ProteoMediX AG Pipeline Products by Indication 6
ProteoMediX AG, Key Facts 7
ProteoMediX AG, Major Products and Services 8
ProteoMediX AG Number of Pipeline Products by Development Stage 9
ProteoMediX AG Pipeline Products Summary by Development Stage 10
Diagnostic Test - Prostate Cancer - Product Status 11
Diagnostic Test - Prostate Cancer - Product Description 11
Prostate Cancer Prognosis Assay - Product Status 12
Prostate Cancer Prognosis Assay - Product Description 12
Prostate Cancer Stratification Assay - Product Status 13
Prostate Cancer Stratification Assay - Product Description 13
ProteoMediX Prostate Cancer Test - Product Status 14
ProteoMediX Prostate Cancer Test - Product Description 14
ProteoMediX AG, Key Employees 16
Glossary 22